NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
Recruiting · NCT06012695 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma | Neoplasms by Site, brain cancer, brain disorder, cancer, central nervous system cancer, central nervous system disorder, neoplasm, nervous system disorder | Recruiting | Phase 1 / Phase 2 | 2026-04-29 | NCT06012695 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novelwise Pharmaceutical Corporation | 3 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Kaohsiung Medical University Chung-Ho Memorial Hospital | Kaohsiung City | Taiwan | 77 |
| Koo Foundation Sun Yat-Sen Cancer Center | Taipei | Taiwan | 15 |
| Linkou Chang-Gung Memorial Hospital | Taoyuan City | Taiwan | 2 |
| Taichung Veterans General Hospital | Taichung | Taiwan | 45 |